1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. OncoCyte Acquires Chronix Biomedical

M&A Deal Summary

OncoCyte Acquires Chronix Biomedical

On October 1, 2020, OncoCyte acquired medical products company Chronix Biomedical

Acquisition Highlights
  • This is OncoCyte’s 1st transaction in the Medical Products sector.
  • This is OncoCyte’s 2nd transaction in the United States.
  • This is OncoCyte’s 1st transaction in California.

M&A Deal Summary
Date 2020-10-01
Target Chronix Biomedical
Sector Medical Products
Buyer(s) OncoCyte
Deal Type Add-on Acquisition

Target

Chronix Biomedical

San Jose, California, United States
Chronix Biomedical is a molecular diagnostics company developing blood tests for use in cancer treatment and organ transplantation. Chronix’s TheraSure CNI Monitor for cancer uses proprietary algorithms to derive a copy number instability (CNI) score from the sequencing of circulating cell-free tumor DNA (cfDNA), which can be used in the prognosis, diagnosis, and monitoring of therapeutic response to cancer. Chronix TheraSure™ Transplant Monitor quantifies the amount of graft-derived cell-free DNA in organ recipients to detect early rejection of organ transplants and better assess the transplant health. Chronix Biomedical was founded in 1997 and is based in San Jose, California.

Search 214,503 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

OncoCyte

Irvine, California, United States
Category Company
Founded 2009
Sector Life Science
Employees46
Revenue 2M USD (2024)
DESCRIPTION

OncoCyte is a molecular diagnostics company. OncoCyte was founded in 2009 and is based in Irvine, California.

DEAL STATS #
Overall 2 of 2
Sector: Medical Products M&A 1 of 1
Type: Add-on Acquisition M&A Deals 2 of 2
State: California M&A 1 of 1
Country: United States M&A 2 of 2
Year: 2020 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2020-01-10 Insight Genetics

Nashville, Tennessee, United States

Insight Genetics, Inc. is a provider of molecular diagnostics that enable precision cancer care. Insight Genetics was founded in 2005 and is based in Nashville, Tennessee.

Buy $12M
Mergr

Solution for

Product

Company

Legal